DL
Dr. Leslie Kean
Founder (leading physician-scientist in transplantation and immune tolerance)
Regatta BioTherapeutic Areas
Regatta Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| EVE Tregs | Chronic Graft-versus-Host Disease (GvHD), Transplant Rejection | Pre-clinical |
| Engineered OX40L CAR-Tregs | Transplant Rejection, Autoimmune Disorders | Pre-clinical |
| CNI-Resistant CAR-Tregs | Solid Organ Transplant Rejection | Pre-clinical |